USPTO 2015–2025 USPTO PatentsView US Corporation

Abb Vie Inc.

USPTO PatentsView assignee record — 604 granted patents across 53 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

604
Total patents granted
53
CPC technology areas
17.7
Avg claims per patent
-71%
5-year filing velocity

Portfolio overview

Abb Vie Inc. has been granted 604 US utility patents between 2015 and 2025, placing Abb Vie Inc. at rank #759 across all assignees tracked by PlainPatent. This portfolio spans 53 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.7 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Abb Vie Inc. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 63.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 136 grants, compared with 468 in the 2015–2019 window — a -71% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Abb Vie Inc.'s 17.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 53 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Abb Vie Inc. against peers pursuing similar technology classes.

How does Abb compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Abb holds 604 patents — placing it at rank #759 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

050100150200 20152016201720182019202020212022202320242025 8
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Abb Vie Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 150 24.8%
2016 120 19.9%
2017 82 13.6%
2018 75 12.4%
2019 41 6.8%
2020 34 5.6%
2021 18 3.0%
2022 21 3.5%
2023 30 5.0%
2024 25 4.1%
2025 8 1.3%

Which technologies does Abb Vie Inc. patent most?

Top 15 of 53 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#759

Across all tracked assignees

Innovation Score

63.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Abb Vie Inc. hold?
Abb Vie Inc. holds 604 US granted patents filed between 2015 and 2025, spanning 53 technology areas.
What is Abb Vie Inc.'s Innovation Score?
Abb Vie Inc. has an Innovation Score of 63.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Abb Vie Inc. focus on?
Abb Vie Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 391 patents. The company has filed patents in 53 CPC subclasses total.
Is Abb Vie Inc.'s patent filing rate increasing or decreasing?
Abb Vie Inc.'s recent filing velocity is -71% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Abb Vie Inc.'s patents?
Abb Vie Inc.'s patents average 17.7 claims each. This falls within the standard range, providing solid legal coverage.
How is the Abb Vie Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope